tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KURA Stock Latest News

Kura Oncology (KURA) Q3 Earnings Cheat Sheet
Pre-EarningsKura Oncology (KURA) Q3 Earnings Cheat Sheet
3d ago
KURA
Kura Oncology’s Promising AML Study: A Potential Game Changer?
PremiumCompany Announcements
Kura Oncology’s Promising AML Study: A Potential Game Changer?
3d ago
KURA
Kura Oncology’s Promising Phase 1 Study on AML Treatment: Key Insights for Investors
PremiumCompany Announcements
Kura Oncology’s Promising Phase 1 Study on AML Treatment: Key Insights for Investors
3d ago
KURA
Kura Oncology’s KO-2806 Study: A New Hope for Advanced Solid Tumors?
PremiumCompany Announcements
Kura Oncology’s KO-2806 Study: A New Hope for Advanced Solid Tumors?
3d ago
KURA
Kura Oncology’s Promising GIST Trial: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Kura Oncology’s Promising GIST Trial: A Potential Game-Changer in Cancer Treatment
4d ago
KURA
Kura Oncology’s Promising Phase 1 Study on Ziftomenib Combinations for AML
PremiumCompany AnnouncementsKura Oncology’s Promising Phase 1 Study on Ziftomenib Combinations for AML
4d ago
KURA
Kura Oncology’s Ziftomenib Study: A Potential Game-Changer in Leukemia Treatment
Premium
Company Announcements
Kura Oncology’s Ziftomenib Study: A Potential Game-Changer in Leukemia Treatment
4d ago
KURA
Promising Prospects for Kura Oncology: Buy Rating Backed by Ziftomenib’s Safety and Market Potential
Premium
Ratings
Promising Prospects for Kura Oncology: Buy Rating Backed by Ziftomenib’s Safety and Market Potential
4d ago
KURA
Kura Oncology’s Competitive Edge in AML Treatment: Favorable Safety Profile of Ziftomenib Drives Buy Rating
PremiumRatings
Kura Oncology’s Competitive Edge in AML Treatment: Favorable Safety Profile of Ziftomenib Drives Buy Rating
4d ago
KURA
Kura Oncology Receives $30M Milestone Payment
PremiumCompany Announcements
Kura Oncology Receives $30M Milestone Payment
7d ago
8K
KURA
Kura Oncology receives $30M development milestone payment for ziftomenib
PremiumThe Fly
Kura Oncology receives $30M development milestone payment for ziftomenib
7d ago
KURA
Promising Phase 1 Trial Results Bolster Buy Rating for Kura Oncology’s FTIs
PremiumRatings
Promising Phase 1 Trial Results Bolster Buy Rating for Kura Oncology’s FTIs
11d ago
KURA
Kura Oncology announces preliminary data from FTI programs
PremiumThe FlyKura Oncology announces preliminary data from FTI programs
12d ago
KURA
Kura Oncology management to meet with Cantor
Premium
The Fly
Kura Oncology management to meet with Cantor
15d ago
KURA
Kura Oncology Expands Inducement Option Plan Shares
Premium
Company Announcements
Kura Oncology Expands Inducement Option Plan Shares
15d ago
8K
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
28d ago
KURA
Kura Oncology, Kyowa Kirin doses first patient of KOMET-007 trial
PremiumThe Fly
Kura Oncology, Kyowa Kirin doses first patient of KOMET-007 trial
30d ago
KURA
Kura Oncology’s Promising Developments in AML Treatment: Buy Rating Affirmed by Joseph Pantginis
PremiumRatings
Kura Oncology’s Promising Developments in AML Treatment: Buy Rating Affirmed by Joseph Pantginis
1M ago
KURA
Kura Oncology announces first patient dosed in KOMET-017 clinical trial
PremiumThe Fly
Kura Oncology announces first patient dosed in KOMET-017 clinical trial
1M ago
KURA
Kura Oncology’s ziftomenib meets primary endpoint in AML study
PremiumThe FlyKura Oncology’s ziftomenib meets primary endpoint in AML study
1M ago
KURA
Promising Developments in Kura Oncology’s FTI Programs Highlighted by Analyst Buy Rating
Premium
Ratings
Promising Developments in Kura Oncology’s FTI Programs Highlighted by Analyst Buy Rating
1M ago
KURA
Kura Oncology’s Strategic Positioning and Promising Developments Justify Buy Rating
Premium
Ratings
Kura Oncology’s Strategic Positioning and Promising Developments Justify Buy Rating
1M ago
KURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >